Metrohm and FOSS have entered into a strategic alliance strengthening the two companies’ leading positions in their respective key markets. In this strategic alliance, Metrohm will become the sole global distributor of FOSS NIR instruments for the chemical, petrochemical, pharmaceutical, and environmental sectors
“Metrohm will extend its product offering beyond the company’s traditional focus on solutions for wet-chemistry analytical techniques thereby benefiting our customers with new possibilities both in laboratory and process analysis”, said Dr. Christoph Fässler, CEO of Metrohm....
Frost & Sullivan will present global trends, challenges and opportunities with a focus on Europe at the 2nd Biosimilars Congregation in London this month
Top representatives from the healthcare industry are confirmed to attend the 2nd Biosimilars Congregation which will take place in London on the 19th and 20th of February 2013. Ranjith Gopinathan, Frost & Sullivan Program Manager for Life Sciences, Europe Practice is set to participate to the event’s Keynote Panel Discussion focusing on challenges and opportunities in the global biosimilars market....
Read MoreVeeva Systems Introduces Regulatory Compliant Email Solution for Global Life Sciences CompaniesFeb 15, 2013
New cloud solution empowers pharmaceutical sales teams with integrated email to maximize productivity
Veeva Systems’ new Approved Email solution is set to radically increase the productivity of life sciences sales teams by enabling users to email approved content to customers directly from iRep and Veeva CRM. Veeva CRM Approved Email represents a technology and business breakthrough in the industry as the first end-to-end solution to enable regulatory compliant email communication between sales reps and healthcare practitioners...
Read MoreLIMS on show at ArabLab 2013Feb 15, 2013
Autoscribe will be demonstrating the flexibility and scalability offered by its flagship Matrix Gemini LIMS (Laboratory Information Management System) at the ArabLab exhibition. Autoscribe will be exhibiting on the booth of its local distributor, Laboratory Automation Services Middle East FX-LLC
Matrix Gemini has applications in a wide range of laboratories including, food, pharmaceutical, chemicals, oil, petrochemicals, veterinary, healthcare, and environmental information management systems. In addition, Matrix Gemini’s Quality Management Suite provides a comprehensive business data management capability and facilitates compliance with ISO 9001 (2008) and ISO/TS 16949 (2002)....
Read MorePolymer nanoparticles used as drug carriers characterized using Nanoparticle Tracking Analysis at Saarland University, SaarbrFeb 14, 2013
NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is used to help with the characterization of polymeric nanoparticles synthesized as drug carrier systems. This work is being carried out at Saarland University, Saarbrücken in Germany by Dr Christian Ruge and his colleagues
In the world of pharmaceutical sciences, a detailed and full characterization of particles synthesized as drug carrier systems is indispensable. The particle size is a crucial parameter to be monitored as this will affect the stability of formulations. It will also impact with respect to size-dependent effects in biological experiments, such as the uptake of drug systems by cells...
Read MoreMicrofluidics specialist Dolomite celebrates a successful 2012Feb 14, 2013
Microfluidics expert Dolomite has reported an exceptional 20% year-on-year growth in 2012
Thanks to the launch of a number of novel microfluidic products including the Porous Media Chip specially designed for petrochemical research, a range of compact Electro-Osmotic Pumps for easy integration into microfluidic systems as well as an innovative Closed-Loop Flow Control System which can be used together with Dolomite’s Mitos P-Pump for better control of micro-scale flow rates
Metrohm is pleased to invite professionals from academic research, public authorities, and the private sector to the 1st Metrohm Environmental Analysis Symposium
Join us in this 3-day event and catch up with the latest analytical methods during presentations and practical demonstrations. Discuss challenges in environmental analysis with experts and colleagues from all over the world and enjoy three days of inspiring learning in the beautiful Appenzellerland. Participants will get to know the latest analytical solutions developed by Metrohm for environmental analysis and can test them in practice. There will be plenty of opportunities to exchange ideas and discuss questions with Metrohm’s application chemists as well as peers from research and various industries. Guest speakers include specialists from environmental laboratories, authorities, standards organizations, and academia...
Scientists at the University of Toronto, Canada, have chosen generations of Tecan microplate readers to monitor the effects of environmental or drug perturbation on molecularly barcoded yeasts
The Corey Nislow and Guri Giaever laboratories – which have recently moved to the Department of Pharmaceutical Sciences at the University of British Columbia – are responsible for monitoring the growth of large pools of barcoded yeast, simultaneously screening 6,000 mutants. Corey explained: “We first developed a workstation for this work in 2000, which consisted of four Tecan GENios™ microplate readers integrated with a multiprobe liquid handler to monitor the growth of cultures....
Read MoreEfficient Tool for Polymer ScreeningFeb 13, 2013
Vortex Overhead Stirring Systems from Asynt Ltd. have helped Parogle Technologies (Liverpool, UK) improve the efficiency with which they synthesise novel dendritic vinyl polymers using solution or emulsion free radical polymerisation reactions
Parogle Technologies, formerly Hydra Polymers Ltd., was formed in 2007 as a spin-off from Unilever plc. to provide products derived from dendritic vinyl polymer technology including methacrylic, styrenic and polyurethane systems. Parogle Technologies exploit the structure and novel 3D shape of their polymers to provide products with superior properties in a wide variety of applications from paints and lubricants to pharmaceuticals and cosmetics...
Read MoreMalvern launches new Imaging Masterclass webinar seriesFeb 12, 2013
Malvern Instruments’ new series of web-based Imaging Masterclasses kicks off on 26 February 2013 with an introduction to imaging for particle characterization
The series will then continue through the year and will cover a broad range of imaging topics. Alongside this will run the laser diffraction Masterclass series which will discuss subjects including wet method development, dry method development, optical property selection and specification setting...
A pioneering drug development team at the University of Aberdeen has received a £1.5M funding boost to accelerate the progress of multiple novel drug leads to tackle cancer and diseases such as debilitating inflammatory conditions
Scottish Enterprise and Biotechnology and Biological Sciences Research Council have provided financial support for the innovative work which takes to the next level research first developed at the University a decade ago, which created novel therapies based on the immune system of one of the most ancient species on the planet - sharks...
Autoscribe has invited a number of biobanking experts to share their views and experiences on how to meet compliance regulations yet retain the flexibility to meet individual application requirements at three seminars to be held in the UK
These free, full-day seminars will be held in London on 7th March, Manchester on 12th March and Edinburgh on 23rd April. These seminars will be of particular interest to anyone involved in biobanks in biotechnology, pharmaceutical and medical research...
Read MoreBioCity Scotland announced as UK hub for major European drug discovery projectFeb 7, 2013
Scottish First Minister Rt. Hon Alex Salmond MSP has welcomed today’s news that a major new pharmaceutical drug discovery initiative is to be centred at BioCity Scotland in Lanarkshire, in partnership with the University of Dundee
The project will bring at least €19 million (£16.3 million) of research funding to Scotland following today’s announcement by the Innovative Medicines Initiative (IMI) of the launch of the European Lead Factory.Accelerating the development of a new generation of drugs is behind the announcement by an international consortium of 30 partners taking part in the European Lead Factory, a novel platform for innovative drug discovery...
Read MoreCarl Zeiss Research Award Goes to Professor Anne L'HuillierFeb 7, 2013
Swedish-French scientist in the field of attosecond physics honored
The winner of this year's Carl Zeiss Research Award, one of the most renowned honors in optics, goes to Professor Anne L’Huillier from Lund University in Sweden. L’Huillier is being honored for her pioneering work in the field of high harmonic generation which has laid the foundation for the generation of attosecond impulses and enabled key advances in attosecond physics."Professor L’Huillier not only described the theory of attosecond technology, but also verified it experimentally”, stated the jury in announcing its decision. Her works enables further development and application of this technology...
Despite challenging economic conditions and in the face of fierce competition, Shimadzu UK has achieved sales order growth of 30% in the last two years
This growth has been achieved across many products in the formidable Shimadzu range including GC, GCMS, LC, LCMS, Spectroscopy, TOC and Material Testing Solutions. A long-established company, Shimadzu is a global presence in mass spectrometry, chromatography, atomic spectroscopy and thermal analysis, and is known for its high quality engineering and robust, technically advanced scientific instrumentation...
EMA and FDA recommend mRNA testing in ADME-Tox studies for superior sensitivity
Plexpress, developer of the innovative TRAC (Transcript Analysis with the aid of Affinity Capture) platform for high-throughput gene expression analysis,has announced dedicated ADME-Tox programs for contract research organizations (CROs). This follows FDA draft guidance suggesting measurement of CYP mRNA levels for ADME-Tox studies, and EMA final guidelines stating that mRNA analysis should be used in drug interaction studies in order to increase the sensitivity of assays...
Worthington Biochemical's NEW 2013-14 Catalog & Product Guide features enzymes, biochemicals and primary cell isolation kits for applications in Life Science Research, Diagnostics & Biotechnology
New and existing products are included for applications in Primary Cell Isolation & Cell Culture, Protein Sequencing, Enzymology & Molecular Biology. New products include Animal Origin Free (AOF) STEMzyme™ Collagenase/Neutral Protease (Dispase®) Blends, Collagenases, DNase, Neutral Protease, RNase and other enzymes for regenerative medicine, biopharma & vaccine production applications...
Read MoreMorphologically directed Raman spectroscopy supports identification of particles in mixed populationsFeb 6, 2013
With the introduction of the Morphologi G3-ID system last year, Malvern Instruments is providing researchers with the ability to apply morphologically directed Raman spectroscopy to a range of different sample types
Such advanced particle analysis is proving valuable and highly effective in applications that include inhaled product characterization and pharmaceutical bioequivalence studies, bioequivalence for nasal sprays being referenced specifically in a talk given by the FDA at this year’s IFPAC conference [January 22-25, 2013 Baltimore, MD, USA]. The use of morphologically targeted Raman spectroscopy has also been described in an independent article, as part of granulation studies, to provide the physical and chemical identities of particles in mixed populations [1]...
Read MoreContract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & SullivanFeb 5, 2013
Ability to provide complete and cost-effective solutions for pharma and biotechnology firms drives uptake of CRO services
Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to invest in state-of-the-art facilities to conduct clinical trials is further advancing market prospects. New analysis from Frost & Sullivan, Analysis of the European Contract Research Outsourcing Markets, finds that the markets earned revenues of approximately $6.07 billion in 2011 and estimates this to reach $11.54 billion in 2018...
Read MoresparkV10 Chosen to Facilitate the Hit Optimization Process in ProMining TherapeuticsFeb 5, 2013
Cresset Group, innovative provider of chemistry software and services, announces that ProMining Therapeutics Ltd has chosen to license sparkV10 for assistance in its hit-to-lead optimization efforts
sparkV10 is Cresset’s desktop bioisostere software tool which is used by medicinal and computational chemists for drug design. sparkV10 is an exciting and powerful way of generating novel and diverse structures. We are delighted that ProMining, an early-stage biopharmaceutical research and development company, has chosen to work with sparkV10 for the development of small molecule drugs,” says Dr David Bardsley, Cresset’s Sales Director...
Read MorePerforming Gas Liquid Chemistries in a Controlled MannerFeb 5, 2013
Using a Uniqsis FlowSyn™ flow reactor system - Sygnature Discovery, a leading provider of integrated drug discovery services to the pharmaceutical industry, has reported results demonstrating how the system allows them to perform traditionally hazardous chemistries in a controlled manner
For example, using the proprietary FlowSyn technology with a Uniqsis GAM IIgas-liquid reactor, laboratory scientists at Sygnature Discovery, in conjunction with Uniqsis, have developed high pressure reaction protocols that have enabled them to reproducibly perform carbonylation chemistries under continuous flow through conditions...
Read MoreProvence Technologies launches new USD 1.7 million (EUR 1.3 million) research programme Feb 4, 2013
Screening 1000, the research project conducted by Provence Technologies, is set up to find and market a new ultra-pure molecule
Provence Technologies, a research laboratory specialising in fine chemistry, announces today the launch of Screening 1000, a new USD 1.7 million (EUR 1.3 million) research programme with the goal of discovering a new ultra-pure molecule for the healthcare market. The project is being launched by the R&D department of Provence Technologies and is being co-financed equally by Oseo, the French innovation promotion agency and Provence Technologies. The programme is planned to run for two years and aims to develop a new range of products...
Read More